Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0006905
UniProt IDP46782
Primary gene name(s)RPS5
Synonym gene name(s)unknown
Protein name40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]
Protein functionunknown
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P46782
Gene Ontology
(Biological Process)
Complete annatation
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];
regulation of translational fidelity [GO:0006450];
ribosomal small subunit assembly [GO:0000028];
rRNA processing [GO:0006364];
SRP-dependent cotranslational protein targeting to membrane [GO:0006614];
translation [GO:0006412];
translational initiation [GO:0006413];
viral transcription [GO:0019083]
Gene Ontology
(Molecular Function)
Complete annatation
mRNA binding [GO:0003729];
poly(A RNA binding [GO:0044822];
RNA binding [GO:0003723];
rRNA binding [GO:0019843];
structural constituent of ribosome [GO:0003735]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
cytosolic small ribosomal subunit [GO:0022627];
extracellular exosome [GO:0070062];
focal adhesion [GO:0005925];
intracellular ribonucleoprotein complex [GO:0030529];
membrane [GO:0016020];
nucleoplasm [GO:0005654]
Protein-protein interaction112107
Phylogenetic treeP46782
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
      Negatively associated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.05538903630808630.8654529013644340.910837660035245
AZA vs. DISU-0.04258947617114330.8658912618692670.991133096247651
AZA vs. IL7-0.06771529843359530.7236631459410710.999311006273513
AZA vs. SAHA-0.1054030761605760.6646951089007560.900281804490708
DISU vs. CD31.6492541128416e-050.9999653843203180.999965384320318
DISU vs. IL7-0.03420501697339040.8917560118671270.98029047000329
DISU vs. SAHA-0.0610662423136230.8335932620418220.957260290477926
DMSO vs. AZA0.02658494497607290.8732092677155391
DMSO vs. CD30.06458453844519160.8397400688880850.888952578019746
DMSO vs. DISU0.06561862506953980.7873677518694420.973311777316403
DMSO vs. IL7-0.08622523808182430.6301295613105370.919906867176379
DMSO vs. SAHA-0.1365476925084570.5612469922296990.844757157684389
HIV vs. Mock in Activation-0.2345276364803650.7070734549746310.999983755607037
HIV vs. Mock in Latency-0.3180664858369370.05294176111741490.905349873021842
IL7 vs. CD3-0.004624249612714920.9885198986433490.993057953433627
SAHA vs. CD3-0.07442910477751180.8329200718095740.882246449852772
SAHA vs. IL7-0.04103510306063960.8658224244111270.944385472183309
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.560063 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.999 0.944 0.923 0.843 0.896
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
0.66 <0.0001 -0.2 0.0605 -0.6 0.0002 Protein Synthesis at 4; 8; and 20 hip
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
4UG0 EM - SF=1-204.
4V6X EM 5.0Å AF=1-204.
5A2Q EM 3.9Å F=1-204.
5AJ0 EM 3.5Å BF=1-204.
5FLX EM 3.9Å F=1-204.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Rev interacts with 22174317
Pr55(Gag) interacts with 26362536

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa03010 Ribosome - Homo sapiens (human)